Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome

@article{Parikh2003NerveGF,
  title={Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome},
  author={V. Parikh and D. R. Evans and M. Khan and S. Mahadik},
  journal={Schizophrenia Research},
  year={2003},
  volume={60},
  pages={117-123}
}
  • V. Parikh, D. R. Evans, +1 author S. Mahadik
  • Published 2003
  • Psychology, Medicine
  • Schizophrenia Research
  • Nerve growth factor (NGF) has been found to play a crucial role in the neuroplasticity of predominantly cholinergic neurons in brain development, and neuronal survival following brain injury, which reflect in cognitive performance. Wide ranges of neurodevelopmental abnormalities have been reported in schizophrenic patients, who also show poor cognitive performance. We report plasma NGF levels in never-medicated first-episode psychotic (FEP; N=24) and chronic medicated schizophrenic patients (N… CONTINUE READING
    87 Citations
    Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients
    • 29
    Brain derived neurotropic factor in first-episode psychosis
    • 146
    Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia
    • 20
    Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia
    • 106
    Impaired nerve growth factor homeostasis in patients with bipolar disorder
    • I. Barbosa, R. B. Huguet, +5 authors A. Teixeira
    • Psychology, Medicine
    • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
    • 2011
    • 54
    Peripheral blood nerve growth factor levels in major psychiatric disorders.
    • 15
    • Highly Influenced
    Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics
    • E. Rizos, A. Papadopoulou, +5 authors L. Lykouras
    • Medicine
    • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
    • 2010
    • 95

    References

    SHOWING 1-10 OF 40 REFERENCES
    Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
    • 326
    • PDF
    Cortical cholinergic markers in schizophrenia
    • 63
    Cognitive function in schizophrenic patients.
    • G. Tollefson
    • Psychology, Medicine
    • The Journal of clinical psychiatry
    • 1996
    • 155
    The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
    • 980
    • PDF
    A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia
    • 131
    The Cognitive Efficacy of Atypical Antipsychotics in Schizophrenia
    • 105
    The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.
    • 679
    • PDF